🧫
experiment

iPSC-derived endothelial cell iron uptake with RLS CSF exposure

🧫 Experiment Protocol Exploratoryrestless legs syndromeTfR1iPSC-derived human endothelial cellsproposed
This experiment investigated iron uptake and transport mechanisms in human endothelial cells (ECs) derived from induced pluripotent stem cells (iPSCs) when exposed to cerebrospinal fluid (CSF) from restless legs syndrome (RLS) patients versus controls. The study aimed to understand how RLS CSF affects blood-brain barrier endothelial cell iron handling, which is relevant to the brain iron deficiency observed in RLS. The researchers measured iron uptake, transport, and related molecular mechanisms including transferrin receptor 1 (TfR1) expression and miR-124-3p levels. The experiment revealed that RLS CSF decreased iron uptake and transport in ECs, and also decreased TfR1 protein expression through increased miR-124-3p binding that reduced TfR1 mRNA stability. This provides mechanistic insight into how brain iron deficiency develops in RLS through altered blood-brain barrier iron transport.
PRIMARY OUTCOME
iron uptake and transport in endothelial cells
EXPECTED OUTCOMES
RLS CSF would alter iron handling in endothelial cells consistent with brain iron deficiency
SUCCESS CRITERIA
Significant differences in iron uptake/transport between RLS CSF and control CSF treated cells
PROTOCOL
Human endothelial cells generated from iPSCs were exposed to CSF from RLS patients (n=14) or controls (n=15). Iron uptake and transport were measured, along with TfR1 protein expression, mRNA stability, and miR-124-3p levels.
LINKED HYPOTHESES
Source: PMID 41947413 ↗
🧫 Experiment Extras
PATHWAY
iron transport/transferrin receptor pathway
MARKET PRICE
$0.50
STATUS
proposed
View on SciDEX ↗